Skip to content

Hemodynamic profiles of remimazolam versus propofol for induction of anesthesia in geriatric patients undergoing major abdominal surgery: A randomized controlled trial

Hemodynamic profiles of remimazolam versus propofol for induction of anesthesia in geriatric patients undergoing major abdominal surgery: A randomized controlled trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200065529
Enrollment
Unknown
Registered
2022-11-08
Start date
2022-11-20
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tumor

Interventions

propofol:propofol 0.5mg/(kg*min)

Sponsors

Fujian Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age over 65 years; 2. American Society of Anesthesiologists (ASA) classification II–III; 3. Scheduled for major abdominal surgery under general anesthesia.

Exclusion criteria

Exclusion criteria: 1. Cardiac insufficiency (EF<40% or NYHA classification III to IV); 2. arrhythmias (such as second- or third-degree atrioventricular block or atrial fibrillation); 3. unstable ischemic heart disease; 4. valvular heart disease with significant hemodynamic fluctuations; 5. received pacemaker implantation; 6. body mass index more than 30; 7. predicted or history of difficulty airway; 8. pyloric or high intestinal obstruction; 9. allergic or contraindications to study drugs; 10. history of drug or alcohol abuse; 11. any other conditions that precluded participation judged by the primary investigator.

Design outcomes

Primary

MeasureTime frame
Area under the baseline MAP over the first 15 min after induction;

Secondary

MeasureTime frame
Area under the baseline CI over the first 15 min after induction;Area under the baseline SVRI over the first 15 min after induction;Area under the baseline HR over the first 15 min after induction;Dosage of vasoactive drugs over the first 15 min after induction;Time to loss of consciousness;BIS values at the time of loss of consciousness;Dosage of study drug at the time of loss of consciousness;

Countries

China

Contacts

Public ContactYusheng Yao

Fujian Provincial Hospital

fjslyys@126.com+86 13559939629

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026